diclofenac |
laboratory |
0.2, 2, and 20
μg L–1
|
Rhamdia quelen
|
increase of superoxide dismutase activity (SOD) in
kidney |
|
diclofenac |
laboratory |
3.08 mg L–1
|
A. altiparanae
|
reduction of testosterone (T) and 17β-Estradiol
(E2) concentration |
|
diclofenac ibuprofen |
laboratory |
3.08 and 13.7 mg L–1
|
A. altiparanae
|
increased thyroxine (T4) in 24 h
|
|
decreased triiodothyronine (T3) concentration at 96 h |
diclofenac |
laboratory |
0.2, 2, and 20 μg L–1
|
Rhamdia quelen
|
reduction of dopamine and metabolite DOPAC
|
|
effects of antioxidant defense on liver
and gonads |
ibuprofen |
laboratory |
0.1, 1,
and 10 μg L–1
|
Rhamdia quelen
|
disturbance on the
antioxidant system
|
|
immunosuppression
|
changes in the
osmoregulation process |
diclofenac |
laboratory |
0.4 μg
L–1
|
A. altiparanae
|
promotion of lipid peroxidation
|
|
inhibition of antioxidant enzymes |
diclofenac |
laboratory |
3.08 mg L–1
|
A. altiparanae
|
SOD and GPx activity inhibition by DCF
|
|
no effect on AChE activity |
ibuprofen diclofenac |
laboratory |
0.1, 1, 10, 100, and 1000 ng L–1
|
A. lacustris
|
reduction of fshβ and lhβ gene expression
|
|
decrease of 11-Ketotestosterone and T concentrations |
diclofenac |
laboratory |
0.2, 2.0, or 20 μg kg–1
|
Hoplias malabaricus
|
alteration of hematological parameters
|
,
|
immunotoxic effects
|
oxidative stress |
diclofenac |
laboratory |
0.2, 2.0, and 20 μg L–1
|
Rhamdia quelen
|
nitric
oxide production was reduced and alteration of 20 anti
inflammatory-related proteins in plasma and kidney proteins |
|